PATENT CLAIM ANALYSIS

Application Number: 15963493
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-04
Patent Classification: ["424", "234100"]

Abstract:
The present invention relates to a probiotic bacteria, and/or soluble metabolite of a probiotic bacteria and/or a cell lysate of a probiotic bacteria for use in the treatment of a disorder associated with Tight Junction function, characterised in that the probiotic bacteria, soluble metabolite of a probiotic bacteria and/or a cell lysate of a probiotic bacteria is formulated for topical administration.

Claim (Index 24):
The method according to  claim 1 , wherein the probiotic bacteria is  Bifidobacterium lactis  420.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 91.0
- Lexical Diversity: 1.9697
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14457916', '12162160', '13118550', '13905197', '13884524']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7507586112057374
- 35 USC 102 Novelty (BERT): 0.5041387852397679
- Combined Prediction Score: 0.7260966286091405
- Mean Citation Score: 244.72032
- Max Citation Score: 255.99248
- Similarity Product: 181.22651835565568

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test